Speaker Date Topic
Dr. Randy Rowe, Teen Challenge CEO Dec 08, 2020
Teen Challenge NorWestCal Nevada
Teen Challenge NorWestCal Nevada

Randy has worked with Teen Challenge since 1979. He started ministering in Denver, CO as the Director of a 40-bed facility. It was there he saw the high value of helping people turn away from their destructive lifestyles.

Randy has a Ph.D in Christian Psychology from International Seminary. His BA is in Biblical Literature from Northwest College, and his MA in Psychology and Counseling from the University of Northern Colorado. Additionally, he is an ordained minister of the Assemblies of God.

In 1984, Randy and his wife, Dana, founded a Teen Challenge Christian Academy in Wyoming. They served 45 students with a residential Junior High/High School education program. Watching confused teens gain control of their lives was amazing. They expanded operations to South Dakota where he helped revitalize an existing program.

In 1996, Randy and Dana took the opportunity to lead the Teen Challenge organization in Northern California and Nevada. They brought the region to a new level of effectiveness and growth. They also opened new centers in Humboldt County, CA, Reno, NV, and Las Vegas, NV.

In 2017, Teen Challenge NorWestCal Nevada opened a new Adolescent Girl's Center in the Nevada territory. This is a dream come true for Randy and Dana who have been praying for this property for years.

A year later, Sacramento Valley Teen Challenge fell under the leadership of Randy and Dana. This includes four centers which are located in Sacramento, Redding, Lincoln, and Yuba City.

Under the guidance and direction of Randy as CEO, Teen Challenge NorWestCal Nevada has grown to include ten residential centers, two thrift stores, and numerous outreaches. Randy also serves on the Board of Directors for Global Teen Challenge.

Laura Gill, Marine Mammal Center Jan 05, 2021
Behind the Bark of Sea Lions and Seals
Behind the Bark of Sea Lions and Seals

Laura Gill is the Community Engagement Manager at The Marine Mammal Center in Sausalito where she leads public program development and implementation, including virtual programs, interpretive resources, and tours. Laura has served in many different education roles at institutions such as Aquarium of the Bay and the Sea Lion Center at San Francisco’s Pier 39, the Roundhouse Aquarium and the Santa Monica Pier Aquarium in Los Angeles, CA which only strengthened her belief that we are all interconnected and dependent on a healthy ocean. Laura was inspired to pursue a career in conservation education after earning her B.S. in Marine Biology from UCSC.

In “Behind The Bark”, I will be sharing a brief history of The Marine Mammal Center’s work with rescue, rehabilitation, release, research, and education and then take a deeper dive into the stories of our common patients including sea lions, elephant seals, and harbor seals.  I’ll describe the challenges they face, how we care for them at the Center, and how people can get involved to protect them and our shared ocean environment.

Dr. Joel Ernst, UCSF Jan 12, 2021
Results of Pfizer and Moderna Covid Vaccine Trials
Results of Pfizer and Moderna Covid Vaccine Trials

Joel Ernst trained in Internal Medicine, Infectious Diseases, and in Hematology and Oncology at the University of California, San Francisco.  He joined the faculty at UCSF where he established a research program in host-pathogen interactions and immunity, and cared for patients with infectious diseases, including the earliest AIDS patients, at San Francisco General Hospital.  He was recruited to the NYU School of Medicine in 2003, where he was Director of the Division of Infectious Diseases and Immunology as well as Director of the Graduate Program in Immunology and Inflammation, and Professor of Medicine, Pathology, and Microbiology.  In 2018, he was recruited to UCSF where he is Professor of Medicine and Chief of the Division of Experimental Medicine. 

COVID-19 is a global pandemic that has changed every aspect of life for billions of people.  The cause is an RNA virus, termed SARS-CoV-2, that is transmitted by the respiratory route and that leads to diverse clinical consequences.  Global control of COVID-19 will depend on development and deployment of vaccines that are safe, able to be produced rapidly in hundreds of millions (or billions) of doses, and inexpensive.  Likewise, preventing complications and mortality requires development and clinical use of drugs that control the infection and that prevent and treat the complications.  This presentation will provide a summary of the present status of drug and vaccine development for COVID-19.